Cerus (CERS)
(Delayed Data from NSDQ)
$2.11 USD
+0.24 (12.83%)
Updated Jul 11, 2024 04:00 PM ET
After-Market: $2.11 0.00 (0.00%) 4:26 PM ET
4-Sell of 5 4
D Value C Growth C Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
CERS 2.11 +0.24(12.83%)
Will CERS be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for CERS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CERS
Cerus (CERS) Reports Q3 Loss, Lags Revenue Estimates
ResMed (RMD) Beats Q1 Earnings and Revenue Estimates
CERS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Cerus (CERS) Reports Q2 Loss, Lags Revenue Estimates
Cerus (CERS) Reports Q1 Loss, Lags Revenue Estimates
Cerus (CERS) Reports Q3 Loss, Tops Revenue Estimates
Other News for CERS
Cerus Corporation Announces Appointment of Dean Gregory to Board of Directors
Cerus Corporation Announces Symposium and Abstracts at the 38th International Congress of the International Society of Blood Transfusion
Cerus announces symposium, abstracts as ISBT
Filtronic reports revenue growth after strong demand in key markets
Cerus Corporation Celebrates World Blood Donor Day 2024